0 NASDAQ Companies - May 4, 2020Green Plains Partners Reports First Quarter 2020 Financial ResultsResults for the First Quarter of 2020Net income of $10.4 million, or $0.44 per common unitAdjusted EBITDA of $13.4 million […]Read More
0 NASDAQ Companies - May 4, 2020OSS to Host AI at the Edge Webinar with Leaders from NVIDIA and MarvellESCONDIDO, Calif., May 04, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge […]Read More
0 NASDAQ Companies - May 4, 2020Sharps Compliance Announces Appointment of Transportation and Logistics Executive Jack Holmes to Board of DirectorsHOUSTON, May 04, 2020 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national […]Read More
0 NASDAQ Companies - May 4, 2020ChemoCentryx to Hold First Quarter 2020 Financial Results Conference Call on Monday, May 11, 2020MOUNTAIN VIEW, Calif., May 04, 2020 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s first quarter […]Read More
0 NASDAQ Companies - May 4, 2020Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual ConferenceWARREN, N.J., May 04, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing […]Read More
0 NASDAQ Companies - May 4, 2020Capitala Finance Corp. Receives “Green Light” from Small Business Administration for Fifth SBIC LicenseCHARLOTTE, N.C., May 04, 2020 (GLOBE NEWSWIRE) — Capitala Group (“Capitala”), a leading provider of capital to lower middle market […]Read More
0 NASDAQ Companies - May 4, 2020PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2020 Financial ResultsFLORHAM PARK, N.J., May 04, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel […]Read More
0 NASDAQ Companies - May 4, 2020Green Plains Reports First Quarter 2020 Financial ResultsResults for the First Quarter of 2020:Net loss attributable to the company of $16.4 million, or $(0.47) per diluted share […]Read More
0 NASDAQ Companies - May 4, 2020GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman SyndromeSARASOTA, Fla. and NOVATO, Calif., May 04, 2020 (GLOBE NEWSWIRE) — GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), […]Read More
0 NASDAQ Companies - May 4, 2020La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2020SAN DIEGO, May 04, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development […]Read More